Weaver Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.3M Sell
6,547
-181
-3% -$64.5K 0.5% 56
2025
Q4
$2.2M Buy
6,728
+215
+3% +$68.2K 0.47% 61
2025
Q3
$1.84M Buy
6,513
+16
+0.2% +$4.64K 0.4% 61
2025
Q2
$1.81M Sell
6,497
-56
-0.9% -$15.9K 0.44% 56
2025
Q1
$2.04M Sell
6,553
-97
-1% -$28.6K 0.54% 46
2024
Q4
$1.73M Buy
6,650
+83
+1% +$24.6K 0.48% 56
2024
Q3
$2.12M Sell
6,567
-518
-7% -$169K 0.63% 46
2024
Q2
$2.21M Sell
7,085
-61
-0.9% -$17.9K 0.71% 39
2024
Q1
$2.03M Buy
7,146
+1,087
+18% +$318K 0.69% 45
2023
Q4
$1.75M Buy
+6,059
New +$1.65M 0.69% 44

Other funds holding AMGN

Weaver Capital Management's AMGN Position: Q1 2026 in Review

Weaver Capital Management reduced its Amgen (AMGN) stake by 2.7% in Q1 2026, selling an estimated $64.5K and leaving 6,547 shares worth $2.3M. The position accounts for 0.5% of the portfolio, ranked #56.

Weaver Capital Management first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Weaver Capital Management held 6,547 shares of Amgen worth $2.3M as of Q1 2026.
  • Weaver Capital Management sold 181 Amgen shares in Q1 2026, an estimated $64.5K.
  • Amgen made up 0.5% of Weaver Capital Management's portfolio in Q1 2026, its #56 holding.
  • Weaver Capital Management first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Weaver Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.